How much funding has CVRx raised?

CVRx has raised $205.6M in total funding, most recently a Venture Round.

Who are CVRx's investors?

CVRx's investors include New Enterprise Associates, Johnson & Johnson Innovation, Strategic HealthCare Investment Partners, Vensana Capital, Big Health, Ysios Capital.

Where is CVRx headquartered?

CVRx is headquartered in Minneapolis.

What industry is CVRx in?

CVRx operates in Healthcare, medical devices, neuromodulation.

CVRx

IPO

Our life goal is to make yours better.

Public · Minneapolis · Founded 2001 · $205.6M raised

Healthcare

medical devices

neuromodulation

Headquarters: Minneapolis
Employees: 51–200
Founded: 2001
Business Model: B2B
Website: cvrx.com

Total Funding: $205.6M
Last Round: $50.0M Venture RoundJul 2020
Rounds: 4
Type: Public

About

CVRx (Nasdaq: CVRX) is a commercial-stage medical device company founded in 2001 and headquartered in Minneapolis, Minnesota. The company develops, manufactures, and commercializes innovative neuromodulation solutions that harness the body's natural systems to improve outcomes for patients with chronic cardiovascular disease. CVRx developed Barostim, the world's first FDA-approved neuromodulation device for heart failure management.

Summary

CVRx is a Healthcare company based in Minneapolis, founded in 2001. It has raised $205.6M in total across 4 rounds, most recently a $50.0M Venture Round round in Jul 2020. Investors include New Enterprise Associates, Johnson & Johnson Innovation and Strategic HealthCare Investment Partners.

LinkedIn X (Twitter)